Vanderbilt’s Diabetes Prevention Program (DPP) has demonstrated its effectiveness at helping employees lose weight as a means of preventing Type 2 diabetes and has received a five-year grant from the National Institutes of Health (NIH) to expand the program using telehealth.

The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

The research suggests that metformin should be further studied clinically for the prevention of liver cancer.

An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.